These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4296847)

  • 1. Cardiovascular actions of guancydine in normotensive and hypertensive animals.
    Cummings JR; Welter AN; Grace JL; Lipchuck LM
    J Pharmacol Exp Ther; 1968 May; 161(1):88-97. PubMed ID: 4296847
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin blocking actions of guancydine.
    Cummings JR; Welter AN; Grace JL; Gray WD
    J Pharmacol Exp Ther; 1969 Dec; 170(2):334-46. PubMed ID: 4311323
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies relating to the antihypertensive and antidysrhythmic action of indoramin.
    Baum T; Shropshire AT; Eckfeld DK; Metz N; Dinish JL; Peters JR; Butz F; Gluckman MI
    Arch Int Pharmacodyn Ther; 1973 Aug; 204(2):390-406. PubMed ID: 4356047
    [No Abstract]   [Full Text] [Related]  

  • 4. General pharmacologic actions of the antihypertensive agent 2,6-dichlorobenzylidene aminoguanidine acetate (WY-8678).
    Baum T; Shropshire AT; Rowles G; Van Pelt R; Fernandez SP; Eckfeld DK; Gluckman MI
    J Pharmacol Exp Ther; 1970 Feb; 171(2):276-87. PubMed ID: 5466490
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased cardiovascular reactivity after bilateral nephrectomy in the rat.
    Basso N; De la Riva IJ
    Acta Physiol Lat Am; 1973; 23(1):1-8. PubMed ID: 4351573
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular profile of BR750 (2,6-dichloro-benzylideneamino-guanidine acetate).
    Marmo E; Saini RK; Caputi AP; Vacca C
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):391-406. PubMed ID: 4750091
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effects of inotropic substances on the heart dynamics and peripheral blood circulation].
    Schüren KP; Buschmann J; Meyer V; Schröder R
    Verh Dtsch Ges Kreislaufforsch; 1968; 34():206-13. PubMed ID: 4899541
    [No Abstract]   [Full Text] [Related]  

  • 8. Opposite effects of amiodarone and -blocking agents on cardiac function under adrenergic stimulation.
    Charlier R; Delaunois G; Bauthier J
    Arzneimittelforschung; 1972 Mar; 22(3):545-52. PubMed ID: 4402603
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat.
    Nekooeian AA; Tabrizchi R
    Br J Pharmacol; 1998 Apr; 123(8):1666-72. PubMed ID: 9605574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs.
    Vatner SF; McRitchie RJ; Braunwald E
    J Clin Invest; 1974 May; 53(5):1265-73. PubMed ID: 4825224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotriene D4 inhibits cardiovascular responses to sympathetic stimulation, angiotensin and vasopressin in the pithed spontaneously hypertensive rats.
    Bayorh MH; Zukowska-Grojec Z; Kopin IJ; Feuerstein G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):85-90. PubMed ID: 6491978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats.
    Nekooeian AA; Tabrizchi R
    Br J Pharmacol; 1998 Oct; 125(4):651-8. PubMed ID: 9831898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective augmentation of the pressor responses to catecholamines by metanephrine.
    Allen DO; Calvert DN; Lum BK
    J Pharmacol Exp Ther; 1969 Jun; 167(2):309-18. PubMed ID: 4306903
    [No Abstract]   [Full Text] [Related]  

  • 14. The sympathoadrenal system mediates the blood pressure and cardiac effects of human coagulation factor XII-related "new pressor protein".
    Mavrogiannis L; Trambakoulos DM; Boomsma F; Osmond DH
    Can J Cardiol; 2002 Oct; 18(10):1077-86. PubMed ID: 12420043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 3rd communication: hemodynamic effects of valsartan in rats and dogs.
    Hayashi N; Yamamoto S; Kometani M; Nakao K
    Arzneimittelforschung; 1997 May; 47(5):620-5. PubMed ID: 9205775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of electric double stimulation and cardio-active drugs on the hypodynamic heart in the dog].
    Urbaszek W; Günther K
    Z Gesamte Inn Med; 1970 Jun; 25(11):480-91. PubMed ID: 4331736
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of lithium chloride on the blood pressure action of renin, angiotensin and noradrenaline in rats].
    Heizmann A; Klaus D
    Verh Dtsch Ges Inn Med; 1967; 73():774-7. PubMed ID: 4298466
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of the bradycardic effect of the antihypertensive agent 2,6-dichlorobenzylidene aminoguanidine acetate (WY-8678) in the anesthetized dog.
    Sherman GP
    Am J Pharm Sci Support Public Health; 1972; 144(4):110-5. PubMed ID: 4655352
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemodynamic effects of a new antihypertensive agent, guanadrel sulfate.
    Cangiano JL; Bloomfield DK
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):736-44. PubMed ID: 4984037
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemodynamic responses to vasopressin before and during infusion of sympathomimetic amines and angiotensin in anesthetized dogs.
    Fregnan GB
    Arzneimittelforschung; 1969 Mar; 19(3):354-6. PubMed ID: 4305821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.